Thrombectomy and thrombolysis in pediatric acute ischemic stroke (S8.007)

Conclusions:In the pediatric AIS population, tPA was associated with increased mortality. Treatment with tPA+/–IAT was associated with decreased discharge home, increased cost, and higher prevalence of ICH. Prevalence of ICH not explained by Moyamoya or sickle cell as those patients were less likely to receive treatment. Limitations include small numbers of treated patients, lack of data on stroke severity or functional outcome, data from years prior to newer thrombectomy devices. Studies of AIS treatment in adults cannot necessarily be extrapolated given the difference in etiologies of pediatric AIS.Disclosure: Dr. Ess has nothing to disclose. Dr. Dafer has received GlaxoSmithKline, Inc., and Endo Pharmaceuticals as a speakers bureau member. Dr. Conners has nothing to disclose. Dr. Cherian has nothing to disclose. Dr. Ouyang has nothing to disclose. Dr. Song has nothing to disclose.
Source: Neurology - Category: Neurology Authors: Tags: Cerebrovascular Disease and Interventional Neurology: Acute Stroke Treatment Source Type: research